Julio Bobes

Julio Bobes's AcademicInfluence.com Rankings

Julio Bobes

Psychology

#3327

World Rank

#3767

Historical Rank

Clinical Psychology

#308

World Rank

#313

Historical Rank

psychology Degrees

Download Badge

Psychology

Why Is Julio Bobes Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Julio Bobes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) (1903)
Suicide prevention strategies revisited: 10-year systematic review. (2016) (999)
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level (2011) (620)
Prevalence of pathological internet use among adolescents in Europe: demographic and social factors. (2012) (612)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study (2019) (401)
Adolescent subthreshold-depression and anxiety: psychopathology, functional impairment and increased suicide risk. (2013) (396)
School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial (2015) (382)
Physical activity in European adolescents and associations with anxiety, depression and well-being (2016) (363)
Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
Life-time prevalence and psychosocial correlates of adolescent direct self-injurious behavior: a comparative study of findings in 11 European countries. (2014) (293)
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. (2013) (269)
Updated European Consensus Statement on diagnosis and treatment of adult ADHD (2018) (247)
Quality of life and disability in patients with obsessive-compulsive disorder (2001) (241)
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study (2007) (229)
Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study (2017) (217)
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. (2014) (210)
Pathological Internet use among European adolescents: psychopathology and self-destructive behaviours (2014) (207)
Frequency of Sexual Dysfunction and Other Reproductive Side-effects in Patients with Schizophrenia Treated with Risperidone, Olanzapine, Quetiapine, or Haloperidol: The Results of the EIRE Study (2003) (199)
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. (2010) (189)
Brain glucose metabolism in borderline personality disorder. (1997) (185)
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort (2010) (169)
Hours of sleep in adolescents and its association with anxiety, emotional concerns, and suicidal ideation. (2014) (164)
Bullying Victimization and Suicide Ideation and Behavior Among Adolescents in Europe: A 10-Country Study. (2017) (164)
Paroxetine in social phobia/social anxiety disorder (1999) (158)
Quality of life in schizophrenic patients (2007) (153)
Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial (2017) (147)
Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study (2003) (135)
Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. (1998) (131)
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. (2010) (127)
Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study (2007) (124)
EPA Guidance on Tobacco Dependence and Strategies for Smoking Cessation in People with Mental Illness (2014) (122)
White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder? (2019) (122)
The prevalence of metabolic syndrome in patients with bipolar disorder. (2008) (120)
[Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia]. (1999) (120)
A European perspective on social anxiety disorder (2000) (115)
Pathological Internet Use and Risk-Behaviors among European Adolescents (2016) (110)
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study (2019) (106)
Quality of life measures in schizophrenia (2005) (104)
New treatment guidelines for acute bipolar mania: a critical review. (2012) (99)
A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study (2008) (95)
Teacher satisfaction with school and psychological well-being affects their readiness to help children with mental health problems (2014) (93)
Bi-directional longitudinal associations between different types of bullying victimization, suicide ideation/attempts, and depression among a large sample of European adolescents. (2018) (89)
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus (2017) (89)
Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence (2006) (82)
Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remission (2009) (81)
Cardiovascular risk in patients with bipolar disorder. (2009) (78)
A Spanish validation study of the mini international neuropsychiatric interview (1998) (72)
The Saving and Empowering Young Lives in Europe (SEYLE) Randomized Controlled Trial (RCT): methodological issues and participant characteristics (2013) (70)
Suicide prevention for youth - a mental health awareness program: lessons learned from the Saving and Empowering Young Lives in Europe (SEYLE) intervention study (2012) (70)
Are older adults also at higher psychological risk from COVID-19? (2020) (70)
Evaluation of the Two-Way Communication Checklist as a clinical intervention (2004) (67)
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study (2018) (65)
Using topiramate or naltrexone for the treatment of alcohol-dependent patients. (2008) (64)
Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample (2020) (63)
Association between victimization by bullying and direct self injurious behavior among adolescence in Europe: a ten-country study (2016) (62)
Risk-behaviour screening for identifying adolescents with mental health problems in Europe (2014) (62)
Pathological Internet Use Is on the Rise Among European Adolescents. (2016) (61)
Association study between obsessive–compulsive disorder and serotonergic candidate genes (2008) (60)
[Predictive validity of the Scale of Prodromal Symptoms (SOPS)]. (2006) (60)
[Evaluation of the psychometric properties of the Spanish version of 5 questionnaires for the evaluation of post-traumatic stress syndrome]. (2000) (59)
A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences. (2011) (59)
COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls? (2020) (57)
Brief assessment of schizotypal traits: A multinational study (2017) (57)
The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety‐related traits (2012) (56)
[A comparative psychometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale]. (2003) (56)
Is attempted suicide different in adolescent and adults? (2008) (54)
Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study (2010) (54)
Spanish adaptation and validation of the Brief Negative Symptoms Scale. (2014) (54)
Results of the COVID-19 mental health international for the general population (COMET-G) study (2021) (53)
Violence among schizophrenia out‐patients compliant with medication: prevalence and associated factors (2009) (53)
Remission in schizophrenia: Results from a 1-year follow-up observational study (2009) (52)
The Network Structure of Schizotypal Personality Traits. (2018) (52)
Quality of Life in Schizophrenia (1997) (52)
Psychometric evaluation of the negative syndrome of schizophrenia (2015) (51)
Sleep-EEG in borderline patients without concomitant major depression: a comparison with major depressives and normal control subjects (2001) (51)
Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD). (2007) (50)
Topiramate for the Treatment of Alcohol Dependence: Comparison with Naltrexone (2010) (50)
Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence (2003) (49)
Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice (2012) (49)
Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients (2013) (47)
Impact of childhood trauma on cognitive profile in bipolar disorder (2017) (47)
How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview (2015) (46)
Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia (2007) (46)
Differential role of serotonergic polymorphisms in alcohol and heroin dependence (2009) (45)
Validation of the Spanish version of the Changes in Sexual Functioning Questionnaire (CSFQ). (2000) (45)
Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia. (2011) (45)
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis (2017) (44)
Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression (2012) (44)
Predictive factors of functional capacity and real-world functioning in patients with schizophrenia (2015) (43)
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study (2017) (43)
Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown? (2020) (43)
Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack? (2014) (43)
Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients (2003) (43)
Assessing and treating alcohol relapse risk in liver transplantation candidates. (2015) (41)
Evidence-based national suicide prevention taskforce in Europe: A consensus position paper (2017) (40)
Impact of substance use on the physical health of patients with bipolar disorder (2009) (40)
Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study. (2019) (40)
Neutrophil-to-lymphocyte ratio: A potential new peripheral biomarker of suicidal behavior (2020) (39)
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case–control study (2020) (39)
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain (2004) (37)
Reasons for Attempted Suicide in Europe: Prevalence, Associated Factors, and Risk of Repetition (2016) (37)
Correlates of sexual initiation among European adolescents (2018) (37)
Psychometric Properties of the Revised Physical and Social Anhedonia Scales in Non-Clinical Young Adults (2009) (37)
[Factors associated with health related quality of life in patients undergoing renal replacement therapy]. (2000) (36)
Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case–control sample from Spain (2014) (36)
Quality of life in schizophrenia: Long-term follow-up in 362 chronic Spanish schizophrenic outpatients undergoing risperidone maintenance treatment (1998) (35)
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis? (2018) (35)
Managing acute exacerbations of schizophrenia: focus on quetiapine (2004) (35)
CIBERSAM: Ten years of collaborative translational research in mental disorders. (2019) (34)
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis (2019) (34)
Clinical features, impulsivity, temperament and functioning and their role in suicidality in patients with bipolar disorder (2016) (34)
Alcohol Consumption Patterns among Adolescents are Related to Family Structure and Exposure to Drunkenness within the Family: Results from the SEYLE Project (2014) (34)
Evaluating Changes in Sexual Functioning in Depressed Patients: Sensitivity to Change of the CSFQ (2002) (34)
Cognition and psychopathology in first-episode psychosis: are they related to inflammation? (2016) (34)
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study (2019) (34)
Treatment adherence and quality of sleep in schizophrenia outpatients (2014) (34)
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme (2020) (33)
Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain (2002) (33)
Multiple somatic symptoms in primary care: A field study for ICD-11 PHC, WHO's revised classification of mental disorders in primary care settings. (2016) (33)
Borderline personality traits in nonclinical young adults. (2011) (32)
Substance use or abuse, internet use, psychopathology and suicidal ideation in adolescents. (2017) (32)
[Validation of the Spanish version of the social adaptation scale in depressive patients]. (1999) (32)
2‐COM: an instrument to facilitate patient–professional communication in routine clinical practice (2002) (32)
Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study (2012) (31)
Validation of a European Spanish-version of the University of California performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorder (2013) (31)
Clinical impact of a gluten-free diet on health-related quality of life in seven fibromyalgia syndrome patients with associated celiac disease (2013) (31)
Help-seeking behaviour following school-based screening for current suicidality among European adolescents (2015) (31)
Psychometric properties of the Spanish version of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) in patients with severe mental disorders. (2011) (31)
Association between the A-1438G polymorphism of the serotonin 2A receptor gene and nonimpulsive suicide attempts (2008) (30)
Walking capacity is associated with health related quality of life and physical activity level in patients with schizophrenia: a preliminary report. (2011) (30)
Factors associated with different smoking status in European adolescents: results of the SEYLE study (2017) (29)
Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls (2018) (29)
It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline (2016) (29)
Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: A corollary from the CLAMORS study (2008) (29)
Measurement Invariance of the Reynolds Depression Adolescent Scale across Gender and Age (2010) (29)
Functional impairment as a defining feature of: amnestic MCI cognitive, emotional, and demographic correlates (2012) (29)
Is the biological nature of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic? Sleep EEG comparison with recurrent brief, major depression and control subjects (2004) (28)
Association between GSK3β gene and increased impulsivity in bipolar disorder (2014) (28)
Antipsychotic switching in bipolar disorders: a systematic review. (2014) (28)
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study (2011) (28)
Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study (2014) (28)
P-259 - Prevalence of Adolescent Depression in Europe (2012) (28)
Oviedo Sleep Questionnaire (OSQ): A new semistructured Interview for sleep disorders (1998) (28)
The incidence of hospital-treated attempted suicide in Oviedo, Spain. (2012) (27)
Early Psychological Correlates Associated With COVID-19 in A Spanish Older Adult Sample (2020) (27)
Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene–environment interaction. The EUGEI study (2019) (27)
Association between the Stin2 VNTR polymorphism of the serotonin transporter gene and treatment outcome in alcohol-dependent patients. (2008) (27)
Pro-/Antiinflammatory Dysregulation in Early Psychosis: Results from a 1-Year Follow-Up Study (2014) (26)
Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study (2013) (25)
Cognitive Performance associated to functional outcomes in stable outpatients with schizophrenia (2015) (25)
Serotonin gene polymorphisms in patients with panic disorder. (2005) (24)
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study (2020) (24)
A cost-effectiveness analysis of school-based suicide prevention programmes (2018) (24)
Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study (2019) (24)
Factors Associated with Hospitalization after Suicide Spectrum Behaviors: Results from a Multicenter Study in Spain (2015) (23)
Association between Heroin Dependence and 5-HT2A Receptor Gene Polymorphisms (2008) (23)
Validation of a Spanish version of the Columbia-Suicide Severity Rating Scale (C-SSRS). (2016) (23)
Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset. (2017) (23)
Suicide prevention in Spain: an uncovered clinical need. (2014) (23)
Interactions between functional serotonergic polymorphisms and demographic factors influence personality traits in healthy Spanish Caucasians (2010) (22)
Life Events Predicting the First Onset of Adolescent Direct Self-Injurious Behavior-A Prospective Multicenter Study. (2020) (22)
Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression. (2002) (22)
Satisfaction with Life of Schizophrenia Outpatients and Their Caregivers: Differences between Patients with and without Self-Reported Sleep Complaints (2013) (22)
24‐Hour opiate detoxification and antagonist induction at home–the ‘Asturian method’: a report on 1368 procedures (2002) (22)
Comorbidity of Physical and Anxiety Symptoms in Adolescent: Functional Impairment, Self-Rated Health and Subjective Well-Being (2018) (22)
Therapeutic advances: Paroxetine for the treatment of social anxiety disorder (2000) (22)
[Interpretation of health-related quality of life of patients on replacement therapy in end-stage renal disease]. (2000) (21)
High degree of tolerability for monotherapy with high doses of quetiapine: a case report. (2002) (21)
The importance of psychosocial interventions and patient involvement in the treatment of schizophrenia (2000) (21)
Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain (2021) (21)
Polymorphisms of the IL-1 gene complex are associated with alcohol dependence in Spanish Caucasians: data from an association study. (2009) (21)
Change in psychiatrists’ attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia (2011) (21)
Role of serotonergic-related systems in suicidal behavior: Data from a case–control association study (2011) (21)
Inverse association between negative symptoms and body mass index in chronic schizophrenia (2017) (20)
Quality of Life in Obsessive-Compulsive Disorder (2000) (20)
Mental health difficulties and suicidal behaviours among young migrants: multicentre study of European adolescents (2017) (19)
Apolipoprotein E genotype and schizophrenia: further negative evidence (2002) (19)
The negative syndrome of schizophrenia: Three -underlying components are better than two (2015) (19)
A longitudinal examination of the interpersonal theory of suicide and effects of school-based suicide prevention interventions in a multinational study of adolescents. (2019) (19)
Effects of the economic crisis on demand due to mental disorders in Asturias: data from the Asturias Cumulative Psychiatric Case Register (2000-2010). (2014) (19)
5-HTTLPR–brain-derived neurotrophic factor (BDNF) gene interactions and early adverse life events effect on impulsivity in suicide attempters (2019) (19)
Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study (2003) (19)
Neurologic soft signs in borderline personality disorder. (2006) (19)
Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes (2015) (19)
Factors associated with tobacco consumption in patients with depression. (2019) (18)
Effects of Pregabalin on Subjective Sleep Disturbance Symptoms during Withdrawal from Long-Term Benzodiazepine Use (2011) (17)
Prevalence of Passive Suicidal Ideation in the Early Stage of the Coronavirus Disease 2019 (COVID-19) Pandemic and Lockdown in a Large Spanish Sample. (2020) (17)
A cross-cultural comparison between Spain and the USA: Temperament and character distribution by sex and age (2011) (17)
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study (2021) (16)
Current status of quality of life assessment in schizophrenic patients (2009) (16)
Interleukin‐1 Gene Complex in Schizophrenia: An Association Study * (2006) (16)
Interconnection between biological abnormalities in borderline personality disorder: Use of the Bayesian networks model (2011) (16)
Safety and effectiveness of olanzapine in monotherapy: A multivariate analysis of a naturalistic study (2005) (16)
Obstetric Phenotypes in the Heterogeneity of Schizophrenia (2018) (16)
[Psychometric performance of the 6th version of the Addiction Severity Index in Spanish (ASI-6)]. (2010) (15)
Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study (2018) (15)
Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology (2019) (15)
Antipsychotic switching in schizoaffective disorder: A systematic review (2016) (15)
Smoking does not impact social and non-social cognition in patients with first episode psychosis (2018) (15)
Risky Drinkers Underestimate their Own Alcohol Consumption. (2017) (15)
The new challenge in identifying the negative syndrome of schizophrenia. (2013) (15)
[Study of effectiveness of craving control with topiramate in patients with substance dependence disorders]. (2004) (14)
Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis (2017) (14)
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings (2021) (14)
Psychopathology is associated with reproductive health risk in European adolescents (2018) (14)
Suicide, unemployment, and economic recession in Spain. (2017) (14)
Psychometric performance of the Oviedo Sleep Questionnaire in patients with severe mental disorder. (2009) (14)
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use. (2019) (14)
Validation of a Spanish version of the Columbia-Suicide Severity Rating Scale (C-SSRS) ☆ (2016) (14)
Principles of Practice from the European Expert Panel on the Contemporary Treatment of Schizophrenia (2000) (14)
Recommendations for switching antipsychotics. A position statement of the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry. (2011) (13)
[Clinical prevalence and reason for visit of patients with generalized anxiety disorder seen in the psychiatry out-patient clinics in Spain. Results of the LIGANDO study]. (2009) (13)
Association of childhood trauma and genetic variability of CRH-BP and FKBP5 genes with suicidal behavior in bipolar patients. (2019) (13)
Effects of Carbamazepine on Dexamethasone Suppression and Sleep Electroencephalography in Borderline Personality Disorder (2002) (13)
Patient characteristics driving clinical utility in psychiatric pharmacogenetics: a reanalysis from the AB-GEN multicentric trial (2018) (13)
Psychosis risk screening: Validation of the youth psychosis at‐risk questionnaire – brief in a community‐derived sample of adolescents (2017) (13)
Bupropion: efficacy and safety in the treatment of depression. (2011) (13)
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients (2017) (13)
Clinical meaningful outcomes in schizophrenia: remission and recovery. (2011) (13)
Perception of Spanish professionals on therapeutic adherence of dual diagnosis patients. (2013) (13)
[Recommendations for the prevention and management of suicidal behaviour]. (2012) (12)
Self-Perceived Needs Are Related to Violent Behavior Among Schizophrenia Outpatients (2011) (12)
How is recovery from social anxiety disorder defined? (1998) (12)
Results of a multinational, randomised controlled trial Results of a multinational, randomised controlled trial (2004) (12)
Influence of coping strategies on the efficacy of YAM (Youth Aware of Mental Health): a universal school-based suicide preventive program (2020) (12)
Dimensional analysis of depressive, anxious and somatic symptoms presented by primary care patients and their relationship with ICD-11 PHC proposed diagnoses (2018) (12)
Use of Cocaine by Secondary School Students in Northern Spain (2003) (12)
Characterizing decision-making and reward processing in bipolar disorder: A cluster analysis (2018) (12)
Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol (2002) (11)
Differential blood-based biomarkers of psychopathological dimensions of schizophrenia. (2016) (11)
Early Impact of the COVID-19 Outbreak on Sleep in a Large Spanish Sample (2021) (11)
Effectiveness of a Multi-Component Smoking Cessation Support Programme (McSCSP) for Patients with Severe Mental Disorders: Study Design (2013) (11)
Psychometric properties of the Spanish version of the screening scale for DSM-IV Generalized Anxiety Disorder of Carroll and Davidson. (2006) (11)
Predictors of Posttreatment Drinking Outcomes in Patients with Alcohol Dependence (2014) (11)
Association study of the interleukin-1 gene complex and tumor necrosis factor alpha gene with suicide attempts (2008) (11)
Assessing the severity of functional impairment of psychiatric disorders: equipercentile linking the mini-ICF-APP and CGI (2019) (11)
Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients. (2017) (11)
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI Study. (2021) (11)
Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement? (2011) (11)
Migration history and risk of psychosis: results from the multinational EU-GEI study (2021) (10)
Cannabis use and cognitive impairment in schizophrenia and first-episode psychosis. (2019) (10)
Spanish consensus on the physical health of patients with depressive disorders. (2014) (10)
Smoking cessation programs for persons with schizophrenia: An urgent unmet need. (2016) (10)
Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population. (2019) (10)
A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs. (2013) (10)
Reading Books and Watching Films as a Protective Factor against Suicidal Ideation (2015) (10)
Doing Nothing is Sometimes Worse: Comparing Avoidant versus Approach Coping Strategies with Peer Victimization and Their Association to Depression and Suicide Ideation (2020) (10)
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design. (2020) (10)
Compulsory admissions of patients with mental disorders: State of the art on ethical and legislative aspects in 40 European countries (2020) (10)
Could structural changes in the retinal layers be a new biomarker of mental disorders? A systematic review and thematic synthesis. (2019) (9)
Why prudence is needed when interpreting articles reporting clinical trial results in mental health (2017) (9)
Quality of Life Instruments in Schizophrenia: a Comperative Study (1996) (9)
Sociodemographic factors associated with personality traits assessed through the TCI (2010) (9)
Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia. (2018) (9)
[Quality of life and disability in chronic schizophrenics treated with with risperidone and previously treated with depot neuroleptics]. (1999) (9)
CIBERSAM: Ten years of collaborative translational research in mental disorders (2019) (9)
Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control Study (2019) (8)
Latent profile analysis of psychosis liability in a community‐derived sample of adolescents: Links with mental health difficulties, suicidal ideation, bipolar‐like experiences and psychotic‐like experiences (2018) (8)
Alcoholism and its treatment approach from a citizen perspective. (2016) (8)
Recurrence of neuroleptic malignant syndrome. (2013) (8)
Predictive factors of alcohol consumption in adolescents: data from 1-year follow-up prospective study. (2019) (8)
Validity and reliability of the Spanish versions of the Bech‐Rafaelsen’s mania and melancholia scales for bipolar disorders (2008) (8)
Recommendations for the prevention and management of suicidal behaviour (2012) (8)
Excessive and pathological Internet use - Risk-behavior or psychopathology? (2021) (8)
Sex-dependent grades of haematopoietic modulation in patients with major depressive episodes are associated with suicide attempts (2020) (8)
Changes in administrative prevalence of mental disorders over a 13-year period in Asturias (northern Spain) (2013) (8)
Network structure of psychotic‐like experiences in adolescents: Links with risk and protective factors (2020) (8)
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway (2020) (8)
Primary care physicians’ use of the proposed classification of common mental disorders for ICD-11 (2017) (7)
[Impact of the spanish consensus on physical health of patients with schizophrenia]. (2010) (7)
[Risperidone in the treatment of psychotic patients with opiate abuse and dependence]. (2001) (7)
Suicide, unemployment, and economic recession in Spain (2017) (7)
Prevalence , impact of medications and disparities in health care WPA EDUCATIONAL MODULE (2011) (7)
Prevention of recurrent suicidal behavior: Case management and psychoeducation (2019) (7)
N-acetyltransferase-2 polymorphisms and schizophrenia (2006) (7)
Association of cannabinoid receptor genes (CNR1 and CNR2) polymorphisms and panic disorder (2020) (7)
Clinical staging in severe mental disorders; bipolar disorder, depression and schizophrenia. (2019) (7)
Factores predictores de riesgo de repetición de intento de suicidio en una muestra de pacientes ambulatorios (2020) (7)
Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia? (2019) (7)
Psychometric properties of the Spanish version of the Body Weight, Image and Self-Esteem Evaluation Questionnaire in patients with severe mental disorders. (2012) (7)
Developments in the treatment of drug dependence (2000) (7)
The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control analysis from the EUGEI study (2019) (7)
Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model (2020) (7)
Genome wide analysis of rare copy number variations in alcohol abuse or dependence. (2018) (7)
The state of psychiatry in Spain (2012) (7)
Lack of association between endothelial nitric oxide synthase (NOS3) gene polymorphisms and suicide attempts (2007) (7)
History of Lifetime Cannabis Use Is Associated with Better Cognition and Worse Real-World Functioning in Schizophrenia Spectrum Disorders (2019) (7)
[Need for the assessment of dual diagnosis in prisons]. (2011) (7)
Twelve-month service use, suicidality and mental health problems of European adolescents after a school-based screening for current suicidality (2020) (6)
Sexual dysfunction in depressed patients undergoing treatment with antidepressants (2000) (6)
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis (2020) (6)
A replication study of JTC bias, genetic liability for psychosis and delusional ideation (2020) (6)
Diagnostic consequences of a new category of anxious depression and a reduced duration requirement for anxiety symptoms in the ICD-11 PHC. (2019) (6)
Immigration and recommended care after a suicide attempt in Europe: equity or bias? (2014) (6)
Recommendations for switching antipsychotics. A position statement of the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry (2011) (6)
Modeling psychological function in patients with schizophrenia with the PANSS: an international multi-center study (2020) (6)
Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia. (2018) (6)
Sixth version of the Addiction Severity Index: Assessing sensitivity to therapeutic change and retention predictors (2011) (6)
Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking (2021) (6)
Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial (2020) (6)
The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study. (2022) (6)
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first‐episode psychosis cohort (2019) (6)
Does COVID-19 psychological fatigue exist? Results of three online cross-sectional studies conducted in Spain from April 2020 to March 2021 (2022) (6)
Gender differences in addiction severity. (2016) (6)
Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder. (2018) (5)
Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: the EU-GEI study (2021) (5)
Obsessive-compulsive disorder: The usefulness of a pharmacological practice guideline. (2016) (5)
Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugs (2002) (5)
Difficulties in delivery and depressive symptomatology in schizophrenia. (2020) (5)
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study (2022) (5)
[Seville Quality of Life Questionnaire: historic outlook of its establishment]. (1999) (5)
Negative evidences in association between apolipoprotein E polymorphism and panic disorder (2006) (5)
[2-COM: presentation of an instrument facilitating communication between physicians and carers in daily practice]. (2007) (5)
Impact of the coronavirus outbreak on mental health in the different Spanish regions. (2021) (5)
“Readiness to Change” Predicts Efficacy of Reduction among Smokers with Severe Mental Illness (2019) (5)
Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia (2018) (5)
Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort) (2019) (5)
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case−control study (2021) (5)
The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting (2007) (5)
[Development of the Spanish brief-version of the University of California Performance Skills Assessment (Sp-UPSA-Brief) in patients with schizophrenia and bipolar disorder]. (2014) (5)
Clinical staging in severe mental disorders: Bipolar disorder, depression and schizophrenia (2019) (4)
[Impact of olanzapine on quality of life of patients with schizophrenia: one-year follow-up with the Seville Quality of Life Questionnaire]. (2004) (4)
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI). (2022) (4)
Personal and social functioning and satisfaction with life in schizophrenia outpatients with and without sleep disturbances (2016) (4)
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study (2021) (4)
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study (2021) (4)
Could structural changes in the retinal layers be a new biomarker of mental disorders? A systematic review and thematic synthesis (2019) (4)
Psychometric properties of a Spanish-version of the Schizophrenia Objective Functioning Instrument (Sp-SOFI) (2015) (4)
Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present. (2017) (4)
The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study (2021) (4)
Función sexual en pacientes deprimidos: relación entre síntomas depresivos y disfunción sexual. Sexual function in depressed patients: relationship between depressive symptoms and sexual dysfunction. (2014) (4)
PW01-171 - Coping Strategies In Adolescents With Psychotic-Like Experiences (2010) (4)
Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia (2022) (4)
Risk Factors and Comorbidities for Occasional and Daily Smoking in European Adolescents: Results of the Seyle Project (2015) (4)
Tobacco and cognitive performance in schizophrenia patients: the design of the COGNICO study. (2016) (3)
[Effectiveness of venlafaxine in the treatment of alcohol dependence with comorbid depression]. (2005) (3)
Exploring the factor structure of the mini-ICF-APP in an inpatient clinical sample, according to the psychiatric diagnosis. (2020) (3)
Influence of secondary sources in the Brief Negative Symptom Scale (2019) (3)
P0067 - Once-daily extended-release Quetiapine Fumarate (Quetiapine XR) monotherapy in generalised anxiety disorder (GAD): A placebo-controlled study with active-comparator Patoxetine (2008) (3)
EPICOG-SCH: A brief battery to screen cognitive impact of schizophrenia in stable outpatients☆ (2017) (3)
Assessing social phobia. The Spanish validation of the sheehan disability scales (1998) (3)
The “Seroquel” Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia (2007) (3)
The Mediating Role of Impulsivity in the Relationship Between Suicidal Behavior and Early Traumatic Experiences in Depressed Subjects (2020) (3)
Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study (2021) (3)
Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences (2020) (3)
Schizophrenia: diagnosis and continuing treatment of Practice from the European Expert Panel on the Contemporary Treatment of Schizophrenia (2000) (3)
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study (2020) (3)
Erratum to “Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression”[J Psychiatr Res (2002) 36 (3) 137–145]☆ (2002) (3)
The Transplant Patient: Quality of life of geriatric patients following transplantation: short- and long-term outcomes (2000) (3)
[Validity of the Spanish version of the Hypersensitive Narcissism Scale (HSNS) in subjects attended at an Addiction Treatment Unit]. (2010) (3)
[Evaluation of the impact of early retirement on the quality of life]. (1998) (3)
Role of serotonergic polymorphisms in the clinical severity of the panic disorder. (2009) (3)
Safety, effectiveness, and patterns of use of olanzapine in acute schizophrenia: a multivariate analysis of a large naturalistic study in the hospital setting. (2005) (3)
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description. (2014) (3)
Psychopathological Symptom Load and Distinguishable Cerebral Blood Flow Velocity Patterns in Patients With Schizophrenia and Healthy Controls: A Functional Transcranial Doppler Study (2021) (3)
[A validation study of the Spanish versions of the Clinical Anxiety Scale and the Physician Questionnaire for the assessment of anxiety disorders]. (2003) (3)
Changes in administrative prevalence of mental disorders over a 13-year period in Asturias (northern Spain). (2013) (3)
Relevant risk factors of repeated suicidal attempts in a sample of outpatients. (2019) (3)
A polygenic approach to the association between smoking and schizophrenia (2021) (3)
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study. (2022) (3)
1827 – Prevalence Of Risk Behaviours Among European Young. Preliminary Data From An Italian Sample We-stay Project (2013) (3)
Cognitive functioning in patients with alcohol use disorder who start outpatient treatment. (2019) (2)
La demencia del rey Fernando VI y el año sin rey (2016) (2)
Utility and validity of the Brief Psychiatric Rating Scale (BPRS) as a transdiagnostic scale (2022) (2)
Role of serotonergic polymorphisms in the clinical severity of the panic disorder (2009) (2)
Suicidal Ideation Trends and Associated Factors in Different Large Spanish Samples During the First Year of the COVID-19 Pandemic. (2022) (2)
[Study protocol of a prevention of recurrent suicidal behaviour program based on case management (PSyMAC)]. (2014) (2)
Possible delayed effect of unemployment on suicide (2016) (2)
[Risperidone in the treatment of acute exacerbation of schizophrenia symptoms]. (1998) (2)
P.6.c.005 Benzodiazepines use withdrawal tapering gradually with pregabalin: findings from the medical practice (2009) (2)
Response to ‘Remarkable prevalence of celiac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study’ – authors’ reply (2014) (2)
Psychiatry residency during the COVID-19 pandemic: Navigating uncharted waters (2020) (2)
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): Rationale, objectives, design and sample description (2014) (2)
Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis (2021) (2)
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study. (2022) (2)
Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology. (2019) (2)
[Open narcissism, covered narcissism and personality disorders as predictive factors of treatment response in an out-patient Drug Addiction Unit]. (2010) (2)
P02.320 Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study) (2000) (2)
Revised Physical Anhedonia Scale--Spanish Version (2019) (2)
Increased risk for mental disorders and suicide during the COVID-19 pandemic: the position statement of the Section on Suicidology and Suicide Prevention of the European Psychiatric Association. (2021) (2)
1857 – Peer Relationships And Adolescents Mental Health: Finding From The Seyle Project In Italy (2013) (2)
A Smart Band for Automatic Supervision of Restrained Patients in a Hospital Environment (2020) (2)
Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms (2021) (2)
The impact of school-based screening on service use in adolescents at risk for mental health problems and risk-behaviour (2022) (2)
Impact of the Spanish Consensus on Physical Health of Patients with Schizophrenia (2010) (2)
Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology (2019) (2)
Clinical Assessment of Alcohol Use Disorders (2020) (1)
Gender, age at onset, and duration of being ill as predictors for the long-term course and outcome of schizophrenia: an international multicenter study (2021) (1)
Development of the Spanish Brief-version of the University of California Performance Skills Assessment (Sp-UPSA-Brief) in patients with schizophrenia and bipolar disorder (2014) (1)
Consensus guideline for the evaluation of physical health in patients with schizophrenia (2007) (1)
P.886 Difficulties in delivery and depressive symptomatology in schizophrenia (2019) (1)
Screening for anxiety and depression in Primary Care: Utility of 2 brief scales adapted to the ICD-11-PC. (2020) (1)
P.859COVID-19 lockdown in people with severe mental disorders in Spain: do they have a specific psychological reaction? (2020) (1)
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study (2023) (1)
Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia. (2020) (1)
Major depression and insomnia assessed through the Oviedo sleep questionnaire (1998) (1)
Barriers to complete recovery of major depression: cross-sectional, multi-centre study on clinical practice. RECORD study. (2018) (1)
Drugs of Abuse and Pharmacotherapies for Substance Use Disorders: An Introduction (2015) (1)
Real-Time Assessment of Stress and Stress Response Using Digital Phenotyping: A Study Protocol (2020) (1)
Relevant risk factors of repeated suicidal attempts in a sample of outpatients (2020) (1)
Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia. (2020) (1)
P.2.031 Quetiapine: Placebo-level prolactin and lowlevels of sexual dysfunction (2004) (1)
Research report Cardiovascular risk in patients with bipolar disorder (2009) (1)
Quality of Life Assessment in Schizophrenia (1999) (1)
Do brain imaging and neurophysiology differentiate borderline personality disorder and depression? (2007) (1)
[Amisulpride for the treatment of alcohol dependence]. (2011) (1)
P0090 - Comorbid symptoms as assessed by Hamilton anxiety scale in outpatients with generalized anxiety disorders (GAD) (2008) (1)
The Trebol study. Quetiapine in the bordeline personality disorder: Patient's attitude and compliance (2007) (1)
Suicide. The post-COVID era: A time for action. (2020) (1)
Early versus late stage schizophrenia. What markers make the difference? (2018) (1)
Smoking in hospitalized patients. A great opportunity. (2020) (1)
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case–Control Study (2022) (1)
Editorial: Issues for DSM-V: I) Including Biological Variables To Objectively Comfort the Clinical Diagnosis of Borderline Personality Disorder and II) Proposing a New Subcategory To Be Included in the Criteria Sets for Further Study (2009) (1)
Study protocol of a prevention of recurrent suicidal behaviour program based on case management (PSyMAC) (2014) (1)
Smoking Status and Cost of Illness in Patients with Depressive Disorder Based on the National Health Survey in Spain (2018) (1)
Unraveling the relationship of loneliness and isolation in schizophrenia: Polygenic dissection and causal inference. (2020) (1)
Safety of olanzapine at doses higher than 20 mg/day versus typical antipsychotics in the treatment of schizophrenic in-patients (EUROPA study) (2001) (1)
Differential Biomarkers of Negative Dimension in Schizophrenia (2015) (1)
Inflammatory and metabolic biomarkers of psychopathological dimensions of schizophrenia (2016) (1)
Schizophrenia and overweight/obesity: Pathophysiology and medical consequences (2007) (1)
[The dementia of King Ferdinand VI and the year with no king]. (2016) (1)
Alcohol use and risk factors for self-harm behavior in Spanish adolescents. (2019) (1)
Cognitive functioning after six months of follow-up in a sample of alcohol use disorder outpatients. (2021) (1)
Attitudes towards suicidal behaviours among health science students (2007) (1)
Quality of life, psychopathological status and drug use in a methadone maintenance treatment in Spain (1998) (1)
Assessing the severity of psychiatric disorders using the Health of the Nation Outcome Scales: An equipercentile linking analysis (2020) (1)
Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia. (2022) (1)
University of Groningen Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples Genetic Risk and Outcome of Psychosis (2020) (1)
Sexual dysfunction in patients with schizophrenia vs bipolar disorder (2011) (1)
Métodos de exploración de la función cognitiva en la práctica clínica (2016) (1)
Factors associated with real-world functioning in first stages of schizophrenia disorder (2021) (0)
W21. ASSOCIATION OF EPIGENETIC MARKERS IN PERIPHERAL BLOOD AND SUICIDAL BEHAVIOR IN BIPOLAR DISORDER (2021) (0)
Effectiveness and safety of olanzapine versus conventional antipsychotics in the treatment of inpatient with acute schizophrenia: A multivariate analysis (2002) (0)
Is it possible to stage schizophrenia? A systematic review (2022) (0)
Poster #99 REPLICATION OF PREVIOUS GWAS STUDIES IN SCHIZOPHRENIA SHOW COMMON RISK SNPS WITH BIPOLAR DISORDER (2012) (0)
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis-findings from the EU-GEI study. (2023) (0)
P.0397 Orexin a in patients with bipolar disorder treated with lithium (2021) (0)
P.2.e.008 Validity and reliability of the Spanish version of the Bech-Rafaelsen's mania (MAS) and melancholia (MES) scales for bipolar disorders (2006) (0)
S2045796020000943jra 1..10 (2020) (0)
T17. OXIDATIVE STRESS BIOMARKERS AND NEGATIVE DIMENSION IN THE FIRST TEN YEARS OF SCHIZOPHRENIA: A 1-YEAR FOLLOW-UP STUDY (2018) (0)
TH77. APPLYING POLYGENIC SCORING OF SEVERE MENTAL DISORDERS TO TEST SHARED VULNERABILITY AND RISK PREDICTION IN PSYCHOTIC DISORDERS (2021) (0)
EPA-0488 - Acute Suicidality in the Spanish Sample of the We-stay Project (2014) (0)
Association between self-reported sleep quality and verbal learning in early stage clinically-stable schizophrenia outpatients (2018) (0)
Schizophrenia Objective Functioning Instrument--Spanish Version (2017) (0)
Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus (2023) (0)
Prevalence of psychological reactions and suicidal ideation during one year of the COVID-19 pandemic in patients with severe mental disorders (2023) (0)
Poster #S168 SPANISH ADAPTATION AND VALIDATION OF THE BRIEF NEGATIVE SYNDROME SCALE (2014) (0)
Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia (2022) (0)
Is antipsychotic-induced weight gain related to sexual dysfunction? (2002) (0)
Differences in Personality Traits Evaluated by TCI According to Physical Illness (2009) (0)
Toxicological and psychological profile of MDMA (ecstasy) abusers and non-abusers in military conscripts (1998) (0)
The King's neurologist (2020) (0)
EPA volume 63 issue S1 Front cover and matter (2020) (0)
P.7.e.003 Sleep in adolescents: association with emotional problems and suicidal ideation (2013) (0)
1655 – Suicide Attempt Prediction In a Controlled Study Of Case Management In The Prevention Of Recurrent Suicidal Behaviour (2013) (0)
P.0647 Psychological impact in patients with common mental disorders after six months of COVID-19 outbreak (2021) (0)
Validation of the Spanish Ve rsion of the Ch anges in Sex ual Fun ctioning Question naire (CSFQ) (2000) (0)
SA104SMOKING CESSATION IMPROVES CLINICAL OUTCOME IN PATIENTS WITH SCHIZOPHRENIA AND IS MODULATED BY GENETIC VARIABILITY AT CHRNA5 GENE (2019) (0)
P.661 Psychological impact of the COVID-19 outbreak and lockdown in Spanish sample with anxiety disorder: differences according to sex (2020) (0)
Nutritional, Metabolic and Endocrine Disorders in Patients with Bipolar Disorder: A Systematic Review (2009) (0)
P.5.009 Effectiveness of a methadone maintenance treatment (MMT) in Spain (1997) (0)
P.3.f.002 Epidemiologic naturalistic study to determine the relationship between the Personal and Social Performance (PSP) scale and the perceived sleep quality in schizophrenia (2012) (0)
The mediating role of impulsivity in the relationship between suicidal behaviour and early traumatic experiences in depressed subjects (2021) (0)
Sociodemographic Profile and Clinical Data of Suicide Attempters from the Emergency Room of the Central Hospital of Asturias (Northern Spain) (2009) (0)
P.378 Metabolic syndrome and quality of life in schizophrenia and bipolar disorder (2019) (0)
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study. (2023) (0)
Prevalence of the metabolic syndrome (MS) in psychotic patients using two proposed NCEP-ATP-III definitions: Results from the clamors study (2007) (0)
P.3.b.040 Obstetric complications and cognitive function in schizophrenia (2017) (0)
GENETICS AND CELL BIOLOGY Association Between the STin2 VNTR Polymorphism of the Serotonin Transporter Gene and Treatment Outcome in Alcohol-Dependent Patients (2008) (0)
T30. ASSESSING SHARED VULNERABILITY AND SEX DIFFERENCES IN PSYCHOTIC DISORDERS USING POLYGENIC SCORING (2022) (0)
Iconographies supplémentaires de l'article : Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice (2012) (0)
Patterns of use of olanzapine in the inpatient treatment of acute schizophrenia: A multivariate approach of the EUROPA study (2003) (0)
Schizophrenia polygenic risk score and cannabis use modify psychosis expression in first episode psychosis patients and population controls (2019) (0)
P0199 - A simulation model to estimate the coronary heart disease risk in schizophrenic patients treated with second-generation-antipsychotic drugs: A Spanish perspective (2008) (0)
P0091 - Demographics and impact of depression comorbidity on clinical and self-perceived health status in outpatients with generalized anxiety disorders (GAD) (2008) (0)
[A reduced version of Thinking and Perceptual Style Questionnaire (TPSQ)]. (2009) (0)
P.3.010 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3β increases the risk of suicidal behaviour in bipolar patients (2012) (0)
TU23. EPIGENETIC AGING IN BIPOLAR PATIENTS WITH SUICIDAL BEHAVIOR (2021) (0)
Checklist as a clinical intervention Results of a multinational , randomised controlled trial (2003) (0)
P.341 Childhood maltreatment in adult depressed patients: impact of types and number of traumas on suicidal behaviour (2019) (0)
PMH41 REMISSION CRITERIA FOR DEPRESSION WHEN USING SHORT VERSIONS OF THE HAMILTON DEPRESSION RATING SCALE (HDRS) (2005) (0)
P01.97 Health status and elderly people (2000) (0)
F12. INFLAMMATORY BIOMARKERS AND COGNITION IN FIRST EPISODE PSYCHOSIS: GENDER DIFFERENCES (2018) (0)
Suicide attempts and suicide ideation in adolescents: SDQ scores in the Spanish sample of “saving and empowering young lives in Europe” (SEYLE) project (2011) (0)
S22 * LIVER TRANSPLANTATION: A EUROPEAN PERSPECTIVE SYMPOSIUM OF THE EUROPEAN FEDERATION OF ADDICTION SOCIETES (EUFAS) II (2013) (0)
The role of genetic variability in the GABRA 6 , 5-HTT and BDNF genes in anxiety-related traits (2013) (0)
University of California Performance Skills Assessment--Spanish Version (2014) (0)
Possible delayed effect of unemployment on suicide in Spain (2016) (0)
S0033291719002794jra 2702..2710 (2021) (0)
Use of multiple Polygenic Risk Scores for distinguishing Schizophrenia-spectrum disorder and Affective psychosis categories; the EUGEI study (2021) (0)
P.586 Comorbid depression in patients with schizophrenia: does it have an impact on their neurocognitive functioning? (2019) (0)
Changes in Sexual Functioning Questionnaire Short-Form—Spanish Version (2014) (0)
Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia. (2022) (0)
Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene (2020) (0)
The Multi-Component Smoking Cessation Support Programme (McSCSP) is effective in patients with severe mental disorder without gender differences. (2020) (0)
1657 – Component Structure Of The Positive And Negative Syndrome Scale (panss) In Patients With Schizophrenia Spectrum Disorders And Predominantly Negative Syndrome (2013) (0)
Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder (2021) (0)
Functional transcranial Doppler: Selection of methods for statistical analysis and representation of changes in flow velocity (2021) (0)
PW01-241 - The Effect Of Pregabalin On Subjective Sleep Problems During Withdrawal From Long-Term Benzodiazepine Use (2010) (0)
[SEMERGEN positioning for the treatment of alcohol disorders in primary care]. (2015) (0)
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case–control study (2023) (0)
[Risperidone: a real alternative for patients treated with depot neuroleptics]. (2000) (0)
Results of the COVID-19 mental health international for the health professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism (2023) (0)
1770 – Pattern Of Tobacco Use And Psychopathology In Patients With Schizophrenia And Bipolar Disorder That Participated In Multicomponent Smoking Cessation Program (2013) (0)
Report of the 3rd European Brain Policy Forum (2011) (0)
Development and validation of predictive model for a diagnosis of first episode psychosis using the multinational EU-GEI case-control study and modern statistical learning methods (2023) (0)
Treatments for Opioid Dependence and Methadone: Neurological and Behavioral Aspects (2016) (0)
COGNITIVEFUNCTIONINGAND CLINICAL SEVERITY AND DRUGATTITUDE IN PSYCHOTIC PATIENTS: RESULTS OF THE CLAMORS STUDY (2008) (0)
Is it Feasible and Effective to Help Patients with Severe Mental Disorders to Quit Smoking? (2017) (0)
P.3.c.037 Neuropsychological performance and cognitive disability in schizophrenia outpatients (2007) (0)
Difficulties in delivery and depressive symptomatology in schizophrenia (2021) (0)
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations (2023) (0)
1st European Conference PAIMM 2001: Care Programs for Health Professionals with Mental Disorders and/or Addiction Behaviours in Europe (2002) (0)
EPA-1110 - Association between truancy and suicidality among european young. preliminary data from an italian sample. we-stay project (2014) (0)
One year follow-up in parasuicidal patients (2001) (0)
P.502 Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis (2020) (0)
P.3.f.023 Brief cognitive battery to monitor stable outpatients with schizophrenia (2015) (0)
261 – Cardiovascular risk in patients with bipolar disorder under treatment (2008) (0)
RECOVERY FROM SCHIZOPHRENIA: STABILITY OF FUNCTIONAL OUTCOME IN PATIENTS ON SYMPTOMATIC REMISSION IN A 1-YEAR EPIDEMIOLOGICAL STUDY (2008) (0)
ORIGINAL RESEARCH—OUTCOMES ASSESSMENT Psychometric Properties of the Spanish Version of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) in Patients with Severe Mental Disorders (2011) (0)
Gynaecological and Obstetric Comorbidities in Patients with Bipolar Disorder: A Systematic Review (2009) (0)
P.2.e.010 Nutritional, metabolic and endocrine disorders in patients with bipolar disorder: a systematic review (2009) (0)
PMH8: SCHIZOPHRENIA OUTCOMES RESEARCH STUDY IN SPAIN: TOLERABILITY AND ECONOMIC RESULTS WITH ATYPICAL ANTIPSYCHOTICS (2001) (0)
1676 – What Is The Relationship Between Coping Styles And Depression In Adolescents? We-stay Project (2013) (0)
[The dementia of King Ferdinand VI and the year with no king. Reply]. (2016) (0)
P.3.c.042 Psychopathology and coronary heart disease (CHD) in psychotic patients with and without deficit: the Clamors study (2007) (0)
S0033291721000453jra 3668..3676 (2022) (0)
A Review of Quality-of-Life Assessment Measures in Schizophrenia: Limitations and Future Developments (2016) (0)
Effects of nicotine abstinence on clinical symptoms. Study at 3 and 6-months follow-up of outpatients with schizophrenia (2016) (0)
Frequency of sleep disturbance in major depression (1998) (0)
Insomnia associated with neutrophil/lymphocyte ratio in female patients with schizophrenia (2021) (0)
S240. DETERMINANT FACTORS OF REAL-WORLD FUNCTIONING IN SCHIZOPHRENIA (2018) (0)
Evaluation of symptomatology on schizophrenia (2009) (0)
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis (2022) (0)
A naturalistic study of reboxetine in the Spanish psychiatric practice (2000) (0)
Paroxetine was effective for reducing symptoms in social phobia (2000) (0)
P.3.a.025 Influence of knowledge of the Spanish consensus on physical health in schizophrenic patients in clinical practice (2009) (0)
Suicide. The post-COVID era: A time for action (2020) (0)
P.2.d.014 Genetic variability at IMPA2 and INPP1 genes is associated to lithium response in bipolar patients (2013) (0)
Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia (2018) (0)
P.3.012 Predictors of second-generation antipsychotic-induced weight gain: a longitudinal study on antipsychotic-naive patients (2014) (0)
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design. (2021) (0)
Barriers to complete recovery of major depression: Cross-sectional, multi-centre study on clinical practice. RECORD study (2019) (0)
[Report of the 3(rd) European Brain Policy Forum]. (2011) (0)
Emotion recognition in major depressed patients: Evidence of lack of relationship with suicidal behavior (2018) (0)
COMT AND DRD3, BUT NOT DRD2, GENOTYPE AFFECT SOFT NEUROLOGICAL SIGNS IN HEALTHY AND FIRST-EPISODE PSYCHOSIS ADOLESCENTS (2008) (0)
Differential peripherical biomarkers in severe mental illness (2016) (0)
Predictors of number and severity of violence episodes in a one-year follow-up schizophrenia sample (2003) (0)
P01.163 For how long can be expected a sustained improvement in schizophrenic patients treated with antipyschotics? A clinical experience with risperidone (2000) (0)
Pro/anti-inflammatory disregulation in early psychosis: results from a longitudinal, case-control study (2015) (0)
Comorbidity of panic disorder and depression: a clinical study (1992) (0)
P.3.c.053 Prevalence of aggressive episodes among ambulatory patients with schizophrenia: focus on past and recent events (2006) (0)
Tobacco Use and Clinical Symptoms in a Sample of Outpatients Diagnosed with Schizophrenia (2015) (0)
Different patient profiles by type of suicidal behavior in an emergency sample (2013) (0)
PMH33 The Cost-Effectiveness of Paliperidone ER in Spain (2011) (0)
[Long term evolution of the incapacity in schizophrenic patients in maintenance treatment with risperidone]. (1999) (0)
Inverse association between negative symptoms and body mass index in chronic schizophrenia Running title : Negative symptoms and body mass index in schizophrenia (0)
P.2.e.009 Gynaecological and obstetric comorbidities in patients with bipolar disorder: a systematic review (2009) (0)
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial (2022) (0)
Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders. (2022) (0)
S0033291720003748jra 1910..1922 (2022) (0)
Intervention strategies in the prevention of suicidal behavior in substance use disorders patients in times of COVID-19. (2021) (0)
Cardiovascular and Respiratory Comorbidities in Patients with Bipolar Disorder: A Systematic Review (2009) (0)
EPA-1616 - EPA Guidance on Tobacco Dependence and Strategies for Smoking Cessation in People with Mental Illness (2014) (0)
PMH12 ECONOMIC CONSEQUENCES OF THE ADVERSE EVENTS RELATED WITH CURRENT ANTIPSYCHOTICS (2003) (0)
W07. Workshop: DO BRAIN IMAGING AND NEUROPHYSIOLOGY DIFFERENTIATE BORDERLINE DISORDER AND DEPRESSION? (2007) (0)
P.3.e.015 Impact of smoking tobacco on healthy life-style habits and 10-year cardiovascular risk in schizophrenia disorders (2009) (0)
COGNITIVEFUNCTIONINGAND PHYSICALHEALTH IN PSYCHOTIC PATIENTS: RESULTS OF THE CLAMORS STUDY (2008) (0)
Risk of violence in hooligans using the PFAV scale (2007) (0)
W76. DECIPHERING THE DYNAMIC ROLE OF MIR-137 TARGETOME IN SCHIZOPHRENIA: TEMPORAL PROFILING AND COMORBIDITY WITH PSYCHIATRIC DISORDERS (2021) (0)
Revised Social Anhedonia Scale--Spanish Version (2019) (0)
P.3.c.050 Psychopathology and metabolic syndrome (MS) in psychotic patients: the CLAMORS study (2006) (0)
P.0564 Active suicidal ideation one year after the beginning of COVID-19 pandemic in a large spanish sample: risk and protective factors (2021) (0)
Prevalence of Metabolic Syndrome and Coronary Heart Disease Risk in Patients with Schizoaffective Disorder: Clamors Study (2009) (0)
P.3.e.01l Tobacco smoking and schizophrenia spectrum disorders in the CLAMORS study: a case-control analysis in the Spanish context (2009) (0)
Adaptation and validation of the Spanish version of the changes in sexual functioning questionnaire (CSFQ): Methodology and results (1998) (0)
Factors associated to persistence of negative symptoms in psychotic patients: Results from the CLAMORS study (2007) (0)
The general problem of increased somatic comorbidity in bipolar patients (2010) (0)
Persistence of negative symptoms in psychotic patients: Results from the CLAMORS study (2007) (0)
Cost-Consequence Analysis of Using Neurofarmagen In The Decision-Making Process During The Treatment of Patients With Depression In The U.S (2017) (0)
Predictive Models of Metabolic Syndrome for Patients with Schizophrenic or Bipolar Disorders (2011) (0)
The Suicide Prevention and Intervention Study (SURVIVE): study protocol for a Spanish multisite cohort study with nested randomized-controlled trials. (2020) (0)
ASSOCIATION STUDY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE (NOS3) POLYMORPHISMS AND SCHIZOPHRENIA (2008) (0)
P.6.d.014 Psychopathological tolerability of varenicline and nicotine patches for smoking cessation in severe mental disorders (2014) (0)
Ecstasy consumption in opiate addicts: Personality disorders and severity of addiction (1998) (0)
Screening for anxiety and depression in Primary Care: Utility of 2 brief scales adapted to the ICD-11-PC. (2021) (0)
P.2.e.008 Cardiovascular and respiratory comorbidities in patients with bipolar disorder: a systematic review (2009) (0)
COVID-19 psychological impact in patients with depressive disorder: Differences based on their age (2021) (0)
Title Correlates of sexual initiation among European adolescents (2019) (0)
Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia. (2021) (0)
EPA-0781 – Psychopathology and Pattern of Tobacco Use in Patients with Schizophrenia. (2014) (0)
82 – Neuropsychological performance and disability in ambulatory patients with schizophrenia (2008) (0)
DRUG USE AND PSYCHOLOGICAL PROFILES IN MILITARY CONSCRIPTS (2010) (0)
S.07.04 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3β increases the risk of suicidal behaviour in bipolar patients (2012) (0)
Association of traumatic events in childhood, impulsivity and decision-making with previous suicide attempt and/or current suicidal ideation in adult patients with major depressive disorder (2021) (0)
Study to determine relevant health outcome measures in opioid use disorder: multicriteria decision analysis. (2020) (0)
P.632 Aggressiveness trait as potentially predictor to suicide attempt in major depressed patients (2019) (0)
Short communication Negative evidences in association between apolipoprotein E polymorphism and panic disorder (2006) (0)

This paper list is powered by the following services:

Other Resources About Julio Bobes

dptomedicina.uniovi.es

What Schools Are Affiliated With Julio Bobes?

Julio Bobes is affiliated with the following schools:

University of Oviedo